Purpose: Chronic Helicobacter pylori gastritis affects two-thirds of the world's population and is one of the most common chronic inflammatory disorders of humans, the infection clearly results in chronic mucosal inflammation in the stomach and duodenum, which, in turn, might lead to abnormalities in gastroduodenal motility and sensitivity and is the most frequent cause of dyspepsia and peptic disease. Some studies showed that there was a correlation between low-grade inflammation as CRP and HP infection. The purpose of this study was to investigate the relationship between the presence of HP infection and platelet/lymphocyte ratio (PLR). Conclusion: Our study indicated, for the first time, a significant association between HP infection and symptoms based on PLR, a simple and reliable indicator of inflammation. Furthermore, there an increase in PLR as the severity of HP increases.
Purpose: Chronic Helicobacter pylori gastritis affects two-thirds of the world's population and is one of the most common chronic inflammatory disorders of humans, the infection clearly results in chronic mucosal inflammation in the stomach and duodenum, which, in turn, might lead to abnormalities in gastroduodenal motility and sensitivity and is the most frequent cause of dyspepsia and peptic disease. Some studies showed that there was a correlation between low-grade inflammation as CRP and HP infection. The purpose of this study was to investigate the relationship between the presence of HP infection and platelet/lymphocyte ratio (PLR).
Method: A total of 200 patients who met the HP criteria and 180 age-and gendermatched control subjects were included in this randomized controlled trial. Patients were diagnosed to have HP according stomach biopsy and urea breath test, PLR was calculated from complete blood count at time of diagnosis and before initiating the treatment.
Results:
Patients with HP infection had significantly higher PLR compared to those without HP. Moreover, the patients with symptomatic HP had higher PLR than those with asymptomatic HP. While PLR increased as the severity of HP symptoms increased (r=.452, P<.001).
Conclusion:
Our study indicated, for the first time, a significant association between HP infection and symptoms based on PLR, a simple and reliable indicator of inflammation. Furthermore, there an increase in PLR as the severity of HP increases.
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| INTRODUCTION
Helicobacter pylori is the most common chronic bacterial infection in humans. 
| PATIENTS AND METHODS

Two hundred patients, who had been diagnosed to have HP infection
in the outpatient clinic according to established criteria for suspected HP infection, were recruited for the study. A total of 180 age-and gender-matched healthy subjects were recruited as the control group.
Patients with uncontrolled hypertension, uncontrolled diabetes, renal failure, hepatic failure, and/or manifest heart disease, such as cardiac failure, coronary arterial disease, arrhythmia, and cardiac valve disease, were excluded. Similarly, patients with infection, acute stress, chronic systemic inflammatory disease, upper or lower gastrointestinal bleeding, and those who had been receiving medications affecting the number of leukocytes were excluded, as well. All the participants included in the study were informed about the study, and their oral and written consents on participating voluntarily were obtained.
Helicobacter pylori was diagnosed according to the National
Institutes of Health (NIH) in 1994. were performed to all patients in addition to urea breath test.
Patients were classified into two groups based on the clinical symptoms of HP: group 1 (patients with asymptomatic HP), group 2 (patients with symptomatic HP), and the control group.
Plasma glucose, urea, creatinine, total cholesterol, TG, HDL, and LDL levels were measured in the venous blood samples obtained in the morning after eight-hour fasting. Complete blood count was studied in our hematology unit with Beckman-Coulter Gen-S system device (Beckman-Coulter Inc., Fullerton, CA, USA). 
| Statistical analysis
| RESULTS
Totally, 200 patients with HP half of them symptomatic and 180 ageand gender-matched subjects were included in the study as patient and control groups respectively. Clinical and vital signs characteristics of both groups are summarized in Table 1 . As shown in Table 2 (Table 3) . 14 Although H. pylori infect the stomach, it has been shown to play a role in the development of numerous non-gastrointestinal diseases.
| DISCUSSION
Researchers suggest that H. pylori induces systemic inflammation
as well as decreases the absorption of nutrients, thereby increasing the risk of several diseases. Some of the conditions associated with H. pylori infection include cardiovascular disease (CVD), stroke, anemia, glaucoma, Alzheimer's disease, rosacea, eczema, chronic hives, diabetes, thyroid disease, and idiopathic thrombocytopenic purpura.
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Eradication treatment of H. pylori can improve numerous conditions, and natural strategies exist to help eradicate this harmful organism.
One study found that eradication treatment of H. pylori increased high-density lipoprotein (HDL) cholesterol, and decreased the inflammatory markers C-reactive protein (CRP) and fibrinogen, which are associated with atherosclerosis and cardiovascular disease risk. 16 Research has shown that the presence of H. pylori antibodies were significantly more frequent in individuals with coronary artery disease (CAD) compared to healthy control subjects. In fact, the presence of antibodies was nearly double in the subjects with CAD compared to the control group, which also correlated with increased CRP levels. 9 Similarly, another study showed that H. pylori infection was related to increased arterial stiffness and increased systolic blood pressure in diabetic subjects.
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Our study is the first to detect an association between HP and other available and simple inflammatory marker to control disease activity, differences between asymptomatic and symptomatic persons strengthen our decision to treat and eradicate the organism and maybe in the future to follow-up after therapy. PLR infrequently practical, despite the simplicity of the test and availability that can be useful in various inflammatory diseases.
Previous studies showed that WBC, leukocyte subtype, and NLR were indicators of systemic inflammation. 18 Number of neutrophils is considered to be associated with formation, complexity, and activation of atheromatous plaque. 19 Consistent with the literature, the present study showed that the number of platelet increased in HP; moreover, the number of platelet increased as symptoms of HP increased. The variation in the increase rate of number of lymphocytes was insignificant between the HP subjects and those without HP. That was considered to be consistent with more increase in the number of platelet compared to that of lymphocytes and hence increase in PLR in the conditions associated with inflammation. In a previous study, NLR was shown to be a predictor in the progression of atherosclerosis.
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The study by Horne and the colleagues found a significant association between the severity and prognosis of CVD, high WBC and NLR.
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Our previous study have demonstrated the usefulness of NLR in HP in small group of patients but we have not examined the utility of PLR.
11
The present study showed that PLR was strongly correlated with the presence of HP and severity of symptoms of HP infection as NLR.
However, associations between PLR and HP have still yet to be investigated in more prospective studies with the correlation of NLR.
PLR, a promising marker of inflammation starting to find a place in the literature, was found to be associated with the presence and the severity HP.
| CONCLUSION
It is known that systemic inflammation is involved in various chronic diseases and sometime can be considered a major risk for 
| Limitations
The most important limitation of the present study was the number of the patients included, in addition the absence of follow-up period after treatment to check the response of therapy and variation of this marker and the correlation with NLR.
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